IMPACT OF EXPOSURE RATE OF PROSTATE SPECIFIC ANTIGEN (PSA) SCREENING ON INCIDENCE OF METASTATIC PROSTATE CANCER IN JAPAN

2009 ◽  
Vol 181 (4S) ◽  
pp. 798-799
Author(s):  
Kazuto Ito ◽  
Takumi Yamamoto ◽  
Mai Miyakubo ◽  
Hiroyuki Takechi ◽  
Masaru Ohi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Metastatic Prostate Cancer ◽  
Specific Antigen ◽  
Exposure Rate ◽  
Psa Screening

Prostate cancer and prostate-specific antigen (PSA) screening in Austria

2005 ◽  
Vol 117 (13-14) ◽  
pp. 457-461 ◽  
Author(s):  
Christian Vutuc ◽  
Eva S. Schernhammer ◽  
Gerald Haidinger ◽  
Thomas Waldhör
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
Psa Screening

Clinical Protocol: Phase I Study of an Adenovirus/Prostate-Specific Antigen Vaccine in Men with Metastatic Prostate Cancer

2006 ◽  
Vol 0 (0) ◽  
pp. 060123080936010
Author(s):  
David M. Lubaroff ◽  
Badrinath Konety ◽  
Brian K. Link ◽  
Timothy L. Link ◽  
Tammy Madsen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Prostate Specific Antigen ◽  
Phase I Study ◽  
Metastatic Prostate Cancer ◽  
Specific Antigen ◽  
Clinical Protocol ◽  
Antigen Vaccine

Response of Prostate-Specific Antigen after Androgen Withdrawal and Prognosis in Men with Metastatic Prostate Cancer

1998 ◽  
Vol 60 (1) ◽  
pp. 28-32 ◽  
Author(s):  
Yuzo Furuya ◽  
Susumu Akimoto ◽  
Koichiro Akakura ◽  
Tatsuo Igarashi ◽  
Shino Murakami ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Metastatic Prostate Cancer ◽  
Specific Antigen ◽  
Androgen Withdrawal

scholarly journals PSA screening for prostate cancer

2017 ◽  
Vol 63 (8) ◽  
pp. 722-725 ◽  
Author(s):  
Marcus V. Sadi
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Early Diagnosis ◽  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
Low Grade ◽  
Psa Screening ◽  
Psa Testing ◽  
Baseline Values

Summary Screening of prostate cancer with prostate-specific antigen (PSA) is a highly controversial issue. One part of the controversy is due to the confusion between population screening and early diagnosis, another derives from problems related to the quality of existing screening studies, the results of radical curative treatment for low grade tumors and the complications resulting from treatments that affect the patient’s quality of life. Our review aimed to critically analyze the current recommendations for PSA testing, based on new data provided by the re-evaluation of the ongoing studies and the updated USPSTF recommendation statement, and to propose a more rational and selective use of PSA compared with baseline values obtained at an approximate age of 40 to 50 years.

Sign in / Sign up

Export Citation Format

Share Document